Table 3.
10 patients (21.7%) of the cohort wit VTE.
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 56 | 70 | 72 | 69 | 67 | 79 | 74 | 81 | 79 | 58 |
| Sex | F | M | M | F | F | M | F | M | M | M |
| DVT | DIST | DIST | PROX | PROX | PROX | NON | PROX | PPROX | DIST | PROX |
| PE | NO | NO | Lobar | NO | NO | Lobar | Lobar | CT ND | CT N D | CT ND |
| D-dimer (<500 ng/mL) | 4631 | 1337 | 25,000 | 19,889 | 700 | 4179 | 7261 | N D | N D | 6821 |
| AST (<37 UI/L) | 55 | 115 | 29 | 47 | 30 | 106 | 59 | 47 | 78 | 58 |
| ALT (<61 UI/L) | 23 | 190 | 37 | 171 | 25 | 174 | 72 | 88 | 44 | 102 |
| Total Bilirubin (1−17um/L) | 13 | 7 | 6 | 11 | 9 | 7 | 9 | 8 | 8 | 9 |
| GammaGT(15−85 UI/L) | 384 | 286 | 95 | ----- | 8 | 308 | 21 | N D | 402 | 102 |
| Alkaline Phosphatase 45−117 UI/L | 84 | 126 | 62 | 253 | 61 | 88 | 56 | N D | 319 | 105 |
| aPTT (0.86−1.20) | 0.83 | 1.13 | 1.08 | 0.85 | 1.03 | 1.36 | 1.07 | 1.05 | 1.21 | 1.11 |
| PT % | 75 | 76 | 76 | 62 | 84 | 65 | 82 | 57 | 84 | 87 |
| GF(> 90 mL/min) | 104 | 97 | 92 | 33 | 90 | 55 | 61 | 63 | 65 | 95 |
| Platelets (166−308 × 10.9/L) | 249 | 478 | 249 | 318 | 208 | 311 | 180 | 689 | 251 | 364 |
| Treatment | T.LMWH | T.LMWH | T.LMWH | T.LMWH | T.LMWH | T.LMWH | T.LMWH | T.LMWH | T.LMWH | T.LMWH |
| ICU | NO | Day 2 | NO | Day 1 | NO | NO | NO | NO | NO | NO |
| Death | NO | NO | NO | NO | NO | Day 6 | NO | NO | NO | NO |
| Bleeding | NO | NO | NO | NO | NO | NO | NO | NO | NO | NO |
T.LMWH = Therapeutic lower molecular weight heparin. Total Bil = Total Bilirubin. DIST = distal. PROX = Proximal CT = Computed tomography. ND =not done. PT = Prothrombin time. P = Patient.